Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04829227 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Sofwave Treatment to Lift Lax Skin
A Phase 3 study of Skin Laxity, sponsored by Sofwave Medical.
- Completed
- Registry status
- Phase 3
- Development phase
- 45
- Enrollment target
- 4
- Study locations
NCT04829227: Completed Phase 3 study of Skin Laxity, sponsored by Sofwave Medical.
NCT04829227 is a Phase 3 study of Skin Laxity that has completed, run by Sofwave Medical. The registered enrollment target is 45 participants, below the 186-participant average among 10 other Skin Laxity trials with a reported enrollment target (76% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04829227, a Phase 3 study of Skin Laxity, has completed, sponsored by Sofwave Medical.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 45 participants
- Enrollment target
- 4
- Study locations
Study Summary
Open-label, non-randomized 2 arms prospective, multi-center, self-controlled clinical study with masked evaluation.
Primary Outcome
as assessed by independent masked evaluators of pre and post treatment images.
Conditions Studied
Interventions
- DEVICE Sofwave
Study Locations (4)
Tennessee
- The Practice of Brian S. Biesman, MD - Nashville
- Tennessee Clinical Research Center - Nashville
New Jersey
- SLSS, a Division of Schweiger Dermatology Group Research Office - Hackensack
Virginia
- McDaniel Institute of Aging Research - Virginia Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2021-12-31 |
| Phase | Phase 3 |
What the finished NCT04829227 record still lists
NCT04829227 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 186-participant average among 10 other Skin Laxity trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which Sofwave is the first listed.
NCT04829227 reports a single indexed study location in Tennessee, New Jersey, Virginia.
Frequently Asked Questions
What is clinical trial NCT04829227 about?
NCT04829227 is a clinical study titled "Safety and Efficacy of Sofwave Treatment to Lift Lax Skin". Open-label, non-randomized 2 arms prospective, multi-center, self-controlled clinical study with masked evaluation.
What is the current status of trial NCT04829227?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 45 participants. The study started on 2020-01-10. Estimated completion is 2021-12-31.
What conditions does trial NCT04829227 study?
This clinical trial studies the following conditions: Skin Laxity.
What interventions are being tested in trial NCT04829227?
The interventions under investigation include: Sofwave (DEVICE).
Who is sponsoring clinical trial NCT04829227?
This trial is sponsored by Sofwave Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04829227 being conducted?
This trial has 4 study locations across New Jersey, Tennessee, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Laxity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04829227's enrollment target sits among peer trials
45 4th of 10 higher than 7 of 10 other Skin Laxity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Laxity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
RECRUITING · NA
-
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
RECRUITING · NA
-
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
RECRUITING · NA
-
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
RECRUITING
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
-
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI